Skip to search formSkip to main contentSkip to account menu

avibactam / Ceftazidime

Known as: AVIBACTAM/CEFTAZIDIME, ceftazidime-avibactam, avibactam - ceftazidime 
National Institutes of Health

Related topics

Related topics

5 relations

Narrower (1)

Avycaz

Broader (2)

Azabicyclo Compoundsbeta-Lactamase Inhibitors
Ceftazidimeavibactam

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2018
Review
2018
Optimizing therapy in CRE infections.
PURPOSE OF REVIEW In the absence of randomized clinical trial data, questions remain regarding the optimal treatment of… 
Highly Cited
2018
Highly Cited
2018
The Inoculum Effect in the Era of Multidrug Resistance: Minor Differences in Inoculum Have Dramatic Effect on MIC Determination
ABSTRACT The observed MIC may depend on the number of bacteria initially inoculated into the assay. This phenomenon is termed the… 
Highly Cited
2017
Highly Cited
2017
Comparison of antimicrobial activity between ceftolozane-tazobactam and ceftazidime-avibactam against multidrug-resistant isolates of Escherichia coli, Klebsiella pneumoniae, and Pseudomonas…
2017
2017
Pharmacokinetics and Dialytic Clearance of Ceftazidime-Avibactam in a Critically Ill Patient on Continuous Venovenous Hemofiltration
ABSTRACT Ceftazidime-avibactam administered at 1.25 g every 8 h was used to treat multidrug-resistant Pseudomonas aeruginosa… 
Highly Cited
2016
Highly Cited
2016
Evaluation of the In Vitro Activity of Ceftazidime-Avibactam and Ceftolozane-Tazobactam against Meropenem-Resistant Pseudomonas aeruginosa Isolates
ABSTRACT We compared ceftazidime-avibactam, ceftolozane-tazobactam, ceftazidime, cefepime, and piperacillin-tazobactam MICs for… 
Review
2016
Review
2016
Treatment options for extended-spectrum beta-lactamase (ESBL) and AmpC-producing bacteria
ABSTRACT Introduction: Extended spectrum β-lactamases (ESBL) and AmpC β-lactamases are increasing causes of resistance in many… 
2016
2016
Assessment of the In Vitro Activity of Ceftazidime-Avibactam against Multidrug-Resistant Klebsiella spp. Collected in the INFORM Global Surveillance Study, 2012 to 2014
ABSTRACT Increasing resistance in Gram-negative bacilli, including Klebsiella spp., has reduced the utility of broad-spectrum… 
Review
2015
Review
2015
The β‐Lactams Strike Back: Ceftazidime‐Avibactam
Gram‐negative resistance has reached a crucial point, with emergence of pathogens resistant to most or all available antibiotics… 
2014
2014
Reclaiming the Efficacy of β-Lactam–β-Lactamase Inhibitor Combinations: Avibactam Restores the Susceptibility of CMY-2-Producing Escherichia coli to Ceftazidime
ABSTRACT CMY-2 is a plasmid-encoded Ambler class C cephalosporinase that is widely disseminated in Enterobacteriaceae and is… 
2013
2013
Antimicrobial Activity of Ceftaroline-Avibactam Tested against Clinical Isolates Collected from U.S. Medical Centers in 2010-2011
ABSTRACT Ceftaroline-avibactam and comparator agents were tested by the broth microdilution method against 20,089 isolates… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)